Skip to main content
Keeps Biopharma Inc. logo

Keeps Biopharma Inc. — Investor Relations & Filings

Ticker · 256940 ISIN · KR7256940008 KO Manufacturing
Open in API
Filings indexed 290 across all filing types
Latest filing 2021-03-22 Annual Report
Country KR South Korea
Listing KO 256940

About Keeps Biopharma Inc.

http://kpscorp.co.kr/

Keeps Biopharma Inc. is a company with operations in both manufacturing and biopharmaceuticals. Its manufacturing activities include the production of equipment for semiconductors and flat panel displays, such as organic light-emitting diodes (OLEDs), as well as cleanroom consumables. Concurrently, the company is expanding its biopharmaceutical business through research and development. Its strategic focus is on building a therapeutic pipeline centered on oncology and metabolic diseases, which includes the development of novel anticancer drugs and combination therapies.

Recent filings

Filing Released Lang Actions
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2020 (Jan 1, 2020 to Dec 31, 2020) for the company KPS. It contains detailed sections including company overview, business operations, financial statements, audit opinions, and governance information. This is the standard Korean regulatory filing equivalent to an Annual Report (10-K). FY 2020
2021-03-22 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (KPS) regarding a correction to a previously disclosed financial report ('매출액 또는 손익구조 30% 이상 변동'). It details specific adjustments to financial line items (operating profit, net income, assets, etc.) due to errors identified during the audit process. Since this is a formal regulatory announcement of financial data adjustments rather than a full annual report or a simple publication notice, it falls under the category of general regulatory filings. FY 2020
2021-03-15 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for KPS (케이피에스). It contains the agenda for the meeting, including the approval of financial statements, changes to the articles of incorporation, and director compensation. It also includes detailed management reference materials (경영참고사항) such as financial statements (balance sheets, income statements) and business overviews. This type of document is standard for proxy solicitation and shareholder information provided ahead of an AGM, fitting the 'Proxy Solicitation & Information Statement' category.
2021-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies, which is a specific regulatory disclosure requirement in the Korean market. Since it does not fit into the specific categories of AGM materials, proxy statements, or financial reports, and is a standard regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2021-03-15 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy/Voting Rights). It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures, and proxy solicitation details. While it includes financial statements, these are provided as part of the proxy materials for shareholder review prior to the meeting. This document is a standard regulatory filing for proxy solicitation in South Korea.
2021-03-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (KPS) announcing a significant change in financial results (30% or more change in revenue or profit structure). This is a standard regulatory disclosure requirement in the Korean market (DART system) for preliminary earnings results before the final audit is completed. Since it provides key financial highlights and explains the reasons for the change, it falls under the 'Earnings Release' category. FY 2020
2021-03-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.